Skip to main content
    1. See Our Science

    • Opportunities for Investigators

    1. Our Science

    Contents

    New discoveries and advancements in patient care rely on the sharing of scientific knowledge and expertise. UCB actively collaborates with a strong global network of internationally renowned scientists, academic institutions, and other leading pharmaceutical companies to support the discovery and evaluation of new treatments.

    Contents

    Clinical Trial Data Sharing

    Through multiple clinical trials in a variety of disease areas, UCB has generated a wealth of data in patients living with severe diseases in immunology and neurology, including rare diseases. UCB is committed to sharing information about our clinical trials and making the results of these studies publicly available. By making patient-level data from UCB clinical studies available to our scientific collaborators, we help support analyses that will inform and guide patient care.

    Qualified researchers may request access to anonymized patient-level data and supporting documents that have been redacted to protect personally identifiable information from UCB-sponsored clinical studies via Vivli.org. Vivli is a multi-sponsor request management system that facilitates the responsible sharing of patient-level data from a range of clinical study Sponsors/Funders through a research-friendly platform.

    In addition to the studies already listed on Vivli.org, UCB will consider ad hoc requests for additional Phase II-IV UCB-sponsored interventional clinical studies that started on or after January 1, 2007 to be added to Vivli.

    Should you have any questions, you can contact us at datasharing.coordinator@ucb.com.
     

    Submit Data Request

    Investigator-Initiated Studies

    Through our Investigator-Initiated Studies program, UCB supports unsolicited and independently initiated and conducted studies that contribute to medical and scientific knowledge and drive advancements in patient care. 

    Therapeutic Areas of Interest in Immunology and Neurology, Including Rare Diseases

    Dermatology

    • Hidradenitis Suppurativa
    • Plaque Psoriasis

    Epilepsy

    • Acute Seizure and Seizure Emergencies, including Seizure Clusters and Prolonged Seizures
    • Developmental and Epileptic Encephalopathies (DEEs)
    • Focal Onset Seizures
    • Rapid and Early Seizure Termination
    • Rare Epilepsies
    • Seizure Action Plans

    Rare Disease

    • Generalized Myasthenia Gravis

    Rheumatology

    • Ankylosing Spondylitis / Radiographic Axial Spondyloarthritis
    • Non-Radiographic Axial Spondyloarthritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus

    As part of this program, UCB accepts unsolicited requests for funding and/or investigational drug supplies to support these studies. Should you have any questions, you may contact your local UCB Medical Science Liaison.

    Submitting a Concept:

    To submit a concept, please click the link below to access the eRequest Online Submission Portal. 

    Submit an IIS Concept

    All concepts submitted will be evaluated by a Review Committee. If a concept is recommended for a full proposal submission, an IIS Team member will contact the applicant with further instructions. 

    For inquiries regarding the IIS process, please email IISmailbox@ucb.com.

    UCB Clinical Trial Investigator

    If you are interested in being an investigator for a UCB-sponsored clinical trial, please forward your curriculum vitae, including a brief description of your therapeutic area specialty, along with the NCT number of the study you are interested in (if applicable) to:

    ucbcares@ucb.com

    Fax: 740-970-8859

    UCB Pharmaceuticals
    1950 Lake Park Drive
    Smyrna, GA 30080